摘要
目的对慢性心力衰竭患者报告结局(PRO)量表进行信度、效度和可行性的评价。方法参考国外的慢性心血管疾病评价工具,编制慢性心力衰竭PRO量表。用该量表对太原不同区的8所医院进行大规模调查,利用大规模调查的信息数据再一次进行条目筛选,形成终量表,并对终量表的信度、效度、可行性进行分析。结果慢性心力衰竭PRO量表共57个条目,对360例患者和100名健康人有效数据进行分析。结果显示:该心力衰竭PRO量表具有较好的信度、效度及临床可行性。总量表的克朗巴赫系数为0.913,生理领域0.903,心理领域0.941,社会领域0.827,治疗领域0.839;内容效度、维度相关性、构念效度、反应度结果显示该表具有良好的效度;此次调查的回收率为98.9%,有效率为98.9%。结论我们研制出的基于慢性心力衰竭患者报告的临床结局评价量表具有较好的信度、效度和可行性,可以作为慢性心力衰竭疾病临床疗效评价研究的工具。
Objective To evaluation the reliability, validity and feasibility of patient-reported outcome （PRO） scale in patients with chronic heart failure （CHIC）. Methods Based on foreign chronic cardiovascular disease assess- ment tools, PRO scale of CHF was developed. This entailed a large-scale formal investigation in 8 hospitals in Taiyuan, which allowed the adjustment of all items in the original scale to establish the final scale, the reliability, va- lidity and feasibility of which was subsequently analyzed. Results The PRO scale of CHF encompassed 57 items, re- sulting from the analysis of 360 patients and 100 healthy individuals, suggesting that the CHF PRO scale has good re- liability, validity and clinical feasibility. Reliability which were verified by the Cronbach coefficient： 0.913, 0.903, 0.941, 0.827 and 0.839 for the total scale, physical, psychological, social and therapeutic domains. The satisfactory validity of CHF PRO was evidenced by the content validity, domain correlation, concept validity and responsiveness. The current survey yielded a total response rate and effectiveness rate of 98.9% and 98.9%, respectively. Conclu- sion The CHF PRO scale in this study has good reliability, validity and feasibility and can be used as a tool for e- valuation of the efficacy of CHF.
出处
《中国药物与临床》
CAS
2014年第3期273-276,共4页
Chinese Remedies & Clinics
基金
国家自然科学基金(81273180)
关键词
心力衰竭
充血性
患者报告结局
信度
效度
Heart failure, congestive
Patient reported outcome
Reliability
Validity
